🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Status
Active Not Recruiting
Location
University of Alabama
Start Date
2022-03-31
Trial ID
NCT05256290
Treatments Being Tested
The goal of this clinical trial is to assess whether the early introduction...
Status
Recruiting
Location
Department of Oncology, Aalborg University Hospital
Start Date
2023-08-22
Trial ID
NCT05947669
Treatments Being Tested
With this research the Investigators hope to learn if early aquapheresis in...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-06-08
Trial ID
NCT04572867
Treatments Being Tested
This 'pragmatic' trial is a 2X2 open randomized study of patients in advanc...
Status
Completed
Location
Carl T. Hayden VA Medical Center
Start Date
2001-01
Trial ID
NCT00050089
Treatments Being Tested
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282
This randomized phase III trial studies how well eribulin mesylate or pacli...
Status
Suspended
Location
Mayo Clinic in Arizona
Start Date
2014-01-17
Trial ID
NCT02037529
Treatments Being Tested
The primary objective of this study is to evaluate the time to confirmed cl...
Status
Completed
Location
Pinnacle Research Group LLC
Start Date
2020-11-24
Trial ID
NCT04590586
Heart failure and atrial fibrillation (AF) often coexist, and each increase...
Status
Unknown
Location
Barts & The London NHS Trust
Start Date
2005-03
Trial ID
NCT01411371
Treatments Being Tested
The purpose of this study is to identify the highest tolerable dose of pyro...
Status
Unknown
Location
Multiple Locations
Start Date
2019-08-15
Trial ID
NCT03997539
Treatments Being Tested
This is an open label, randomized, Phase II multicenter study designed to e...
Status
Withdrawn
Location
Asklepios Fachkliniken München-Gauting
Start Date
2022-05-20
Trial ID
NCT05383001
Treatments Being Tested